
501 - 1000 employees
Founded 2014
🏥 Healthcare
đź’Ľ Consulting
🏠Manufacturing
đź’° $350M Post-IPO Equity - Autolus on 2024-02
Healthcare • Consulting • Manufacturing
Autolus Therapeutics is a clinical-stage biotechnology company developing next-generation autologous CAR T cell therapies for cancer and autoimmune diseases. The company applies advanced cell programming, proprietary viral vectors, and semi-automated T cell manufacturing to engineer precision CAR T products, and is advancing a pipeline that includes programs for hematological malignancies, solid tumors, and autoimmune indications. Autolus emphasizes integrated development and commercialization efforts, clinical trials, and publication of its research.
đź•’ July 31
Improve your chances of getting an interview by checking your resume score before you apply.

501 - 1000 employees
Founded 2014
🏥 Healthcare
đź’Ľ Consulting
🏠Manufacturing
đź’° $350M Post-IPO Equity - Autolus on 2024-02
Healthcare • Consulting • Manufacturing
Autolus Therapeutics is a clinical-stage biotechnology company developing next-generation autologous CAR T cell therapies for cancer and autoimmune diseases. The company applies advanced cell programming, proprietary viral vectors, and semi-automated T cell manufacturing to engineer precision CAR T products, and is advancing a pipeline that includes programs for hematological malignancies, solid tumors, and autoimmune indications. Autolus emphasizes integrated development and commercialization efforts, clinical trials, and publication of its research.
• The MSL is responsible for scientifically engaging, collaborating and aligning with a broad range of external stakeholders to address identified patient needs and ultimately improve the practice of medicine for better patient access and outcomes. • MSLs leverage the right evidence at the right time during their scientific engagements and identify medical intelligence and opportunities that impact and inform medical scientific communication and collaboration, science data generation plans, launch excellence roadmap, patient journey and medical strategy. • Partnering with health systems and identifying external medical intelligence, data gaps, data generation opportunities (including RWE and implementation science, precision medicine, research collaborations), and key unmet needs and opportunities to help improve patient access and outcomes. • In collaboration with clinical research colleagues, support clinical trial process, including, but not limited to, research site recommendations, assistance in managing Investigator relationships, providing medical expertise when required. • Able to create personalised, flexible engagement strategies and plans, leveraging multiple channels and tailored content to meet the changing needs of external stakeholders.
• Five years of MSL, or relevant industry, experience with CAR T launch experience and extensive knowledge of hematologic malignancies. • Allopathic or Osteopathic Medical degree. • Pharm.D., PhD, Doctor of Nursing Practice, or an APP (MSN/Nurse Practitioner or MS/Physician Assistant, other Terminal degree in health/life sciences (preferred). • Bachelors of Science in Nursing with a minimum of 5 years experience in patient care and/or clinical research focused on hematologic malignancies, combined with 5 years of relevant industry experience focused on CART therapies.
• Competitive salary • Performance related bonus • Private medical insurance • Life assurance • Pension
Apply Nowđź•’ July 31
Medical Science Liaison II supporting KOLs and healthcare providers remotely across the West Region. Engaging in scientific dialogue and maintaining relationships while providing insights to inform strategy.
🇺🇸 United States – Remote
đź’µ $164.9k - $226.8k / year
⏰ Full Time
đźź Senior
đź”´ Lead
🦅 H1B Visa Sponsor
đź•’ July 31
Medical Science Liaison II supporting academic and community healthcare providers in the Pacific Northwest for cancer therapies. Building relationships and delivering scientific expertise across various settings.
🇺🇸 United States – Remote
đź’µ $164.9k - $226.8k / year
⏰ Full Time
đźź Senior
đź”´ Lead
🦅 H1B Visa Sponsor
đź•’ July 30
Medical Science Liaison advancing Natera’s GI oncology genetic testing and Signatera MRD diagnostics. Educating providers, supporting Medical Affairs initiatives, and translating field insights into patient-care impact.
🇺🇸 United States – Remote
đź’µ $145k - $175k / year
⏰ Full Time
🟡 Mid-level
đźź Senior
🦅 H1B Visa Sponsor
đź•’ July 29
Field-based Medical Science Liaison responsible for KOL engagement and scientific exchange in dermatology. Joining a dynamic team at Veradermics, focused on innovative therapeutics for skin conditions.
đź•’ July 29
51 - 200
Medical Science Liaison focusing on strategic partnerships and evidence generation for obesity therapies at Kailera Therapeutics. Building Field Medical Affairs from the ground up.
🇺🇸 United States – Remote
đź’µ $196k - $235k / year
🔥 Funding within the last year
đź’° $600M Series B - Kailera Therapeutics on 2025-10
⏰ Full Time
🟢 Junior
🟡 Mid-level